Naproxen belongs to the nonsteroidal anti-inflammatory drugs (NSAIDs) class of drugs. It is used to relieve pain from muscle aches, tendonitis, headache, menstrual cramps and dental pain. It also reduces swelling, pain, and joint stiffness due to arthritis, bursitis, and gout attacks. The drug has anti-inflammatory, analgesic, and antipyretic properties.
MARKET DYNAMICS
The naproxen market is driving due to the increasing prevalence of arthritis, and growing focus on treating pain and swelling caused due to arthritis and other chronic conditions. Moreover, growing pharmaceutical industry in the developing nations is likely to create growth opportunities in the market.
MARKET SCOPE
The "Naproxen Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of naproxen market with detailed market segmentation by formulation, indication and distribution channel. The naproxen market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in naproxen market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The naproxen market is segmented on the basis of formulation, indication and distribution channel. Based on formulation, the market is segmented as oral tablets, and liquid suspension. Based on indication, the market is segmented as osteoarthritis (OA), rheumatoid arthritis (RA), ankylosing spondylitis, juvenile arthritis, bursitis, menstrual cramps, gout, and tendonitis. Distribution channel segment is segmented into hospital pharmacies, retail pharmacies, drug stores, and e-commerce.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the naproxen market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The naproxen market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting naproxen market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the naproxen market in these regions.
MARKET PLAYERS
The report covers key developments in the naproxen market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from naproxen market are anticipated to have lucrative growth opportunities in the future with the rising demand for naproxen market in the global market. Below mentioned is the list of few companies engaged in the naproxen market.
The report also includes the profiles of key players in naproxen market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Teva Pharmaceuticals
- Kirsch Pharma GmbH
- Aurobindo
- Divis Laboratories
- Taj Pharmaceuticals Limited
- Tianxin Pharmaceutical
- Charioteer Pharmaceutical
- Nhwa Pharmaceutical
- Huazhong Pharma
- Dr. Reddy's Laboratories Ltd.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.